Ventricular assist devices or inotropic agents in status 1A patients? Survival analysis of the united network of organ sharing database

Annals of Thoracic Surgery

Volumn 97, Issue 4, 2014, Pages 1364-1372

  Wozniak, Curtis J ^a   Stehlik, Josef ^b   Baird, Bradley C ^d   McKellar, Stephen H ^d   Song, Howard K ^c   Drakos, Stavros G ^b   Selzman, Craig H ^d  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INOTROPIC AGENT;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; CLINICAL CLASSIFICATION; COHORT ANALYSIS; CONTROLLED STUDY; DATA BASE; DEVICE SAFETY; DRUG MEGADOSE; DRUG TREATMENT FAILURE; FEMALE; GRAFT RECIPIENT; HAZARD RATIO; HEART TRANSPLANTATION; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; INTRAAORTIC BALLOON PUMP; LEFT VENTRICULAR ASSIST DEVICE; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; MIDDLE AGED; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SECONDARY ANALYSIS; SURVIVAL; SURVIVAL TIME;

CARDIOTONIC AGENTS; DATABASES, FACTUAL; FEMALE; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TISSUE AND ORGAN PROCUREMENT;

EID: 84898601814     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2013.10.077     Document Type: Article

References (18)

1. L.H. Lund, L.B. Edwards, and A.Y. Kucheryavaya et al. The Registry of the International Society for Heart and Lung Transplantation: thirtieth official adult heart transplant report-2013; focus theme: Age J Heart Lung Transplant 32 2013 951 964
2. D.A. Bull, B.B. Reid, and C.H. Selzman et al. The impact of bridge-to-transplant ventricular assist device support on survival after cardiac transplantation J Thorac Cardiovasc Surg 140 2010 169 173
3. J.N. Nativi, S.G. Drakos, and A.Y. Kucheryavaya et al. Changing outcomes in patients bridged to heart transplantation with continuous- versus pulsatile-flow ventricular assist devices: an analysis of the registry of the International Society for Heart and Lung Transplantation J Heart Lung Transplant 30 2011 854 861
4. J. Stehlik, L.B. Edwards, and A.Y. Kucheryavaya et al. The registry of the International Society for Heart and Lung Transplantation: 29th official adult heart transplant report - 2012 J Heart Lung Transplant 31 2012 1052 1064
5. R.C. Starling, Y. Naka, and A.J. Boyle et al. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) J Am Coll Cardiol 57 2011 1890 1898
6. A.H. Healy, B.C. Baird, S.G. Drakos, J. Stehlik, and C.H. Selzman Impact of ventricular assist device complications on posttransplant survival: an analysis of the United Network of Organ Sharing database Ann Thorac Surg 95 2013 870 875
7. N. Moazami, and D. Feldman Rethinking the terminology of mechanical circulatory support J Thorac Cardiovasc Surg 144 2012 2 3
8. T. Dardas, N.A. Mokadam, F. Pagani, K. Aaronson, and W.C. Levy Transplant registrants with implanted left ventricular assist devices have insufficient risk to justify elective organ procurement and transplantation network status 1a time J Am Coll Cardiol 60 2012 36 43
9. J.C. Cleveland Jr., F.L. Grover, and D.A. Fullerton et al. Left ventricular assist device as bridge to transplantation does not adversely affect one-year heart transplantation survival J Thorac Cardiovasc Surg 136 2008 774 777
10. J.S. Gammie, L.B. Edwards, B.P. Griffith, R.N. Pierson 3rd, and L. Tsao Optimal timing of cardiac transplantation after ventricular assist device implantation J Thorac Cardiovasc Surg 127 2004 1789 1799
11. B.E. Jaski, J.C. Kim, and D.C. Naftel et al. Cardiac transplant outcome of patients supported on left ventricular assist device vs. intravenous inotropic therapy J Heart Lung Transplant 20 2001 449 456
12. R. John, F.D. Pagani, and Y. Naka et al. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables J Thorac Cardiovasc Surg 140 2010 174 181
13. J.A. Morgan, Y. Park, and A.R. Kherani et al. Does bridging to transplantation with a left ventricular assist device adversely affect posttransplantation survival? A comparative analysis of mechanical versus inotropic support J Thorac Cardiovasc Surg 126 2003 1188 1190
14. J.D. Pal, V. Piacentino, and A.D. Cuevas et al. Impact of left ventricular assist device bridging on posttransplant outcomes Ann Thorac Surg 88 2009 1457 1461 discussion 1461
15. M.J. Russo, K.N. Hong, and R.R. Davies et al. Posttransplant survival is not diminished in heart transplant recipients bridged with implantable left ventricular assist devices J Thorac Cardiovasc Surg 138 2009 1425 1432.e1-3
16. V. Patlolla, R.D. Patten, D. Denofrio, M.A. Konstam, and R. Krishnamani The effect of ventricular assist devices on post-transplant mortality an analysis of the United Network for Organ Sharing thoracic registry J Am Coll Cardiol 53 2009 264 271
17. O. Wever-Pinzon, S.G. Drakos, and A.G. Kfoury et al. Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United Network for Organ Sharing thoracic organ allocation policy justified? Circulation 127 2013 452 462
18. T. Karamlou, J. Gelow, and B.S. Diggs et al. Mechanical circulatory support pathways that maximize post-heart transplant survival Ann Thorac Surg 95 2013 480 485 discussion 485